Effects of a perindopril-based blood pressure-lowering regimen on disability and dependency in 6105 patients with cerebrovascular disease: a randomized controlled trial.

PubWeight™: 1.11‹?› | Rank: Top 10%

🔗 View Article (PMID 12958329)

Published in Stroke on September 04, 2003

Authors

M Fransen1, C Anderson, J Chalmers, N Chapman, S Davis, S MacMahon, B Neal, R Sega, A Terent, C Tzourio, M Woodward, PROGRESS

Author Affiliations

1: Institute for International Health, University of Sydney, Sydney, Australia.

Articles by these authors

Blood pressure, stroke, and coronary heart disease. Part 2, Short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context. Lancet (1990) 24.72

Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. Science (1997) 15.48

Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial. Lancet (2007) 14.96

Vascular-specific growth factors and blood vessel formation. Nature (2000) 14.42

Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Second European-Australasian Acute Stroke Study Investigators. Lancet (1998) 14.00

Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis. Cell (1996) 13.95

Effects of ACE inhibitors, calcium antagonists, and other blood-pressure-lowering drugs: results of prospectively designed overviews of randomised trials. Blood Pressure Lowering Treatment Trialists' Collaboration. Lancet (2000) 9.78

Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease. Nat Genet (2013) 9.46

Imaging beta-amyloid burden in aging and dementia. Neurology (2007) 7.70

Reduction of postoperative mortality and morbidity with epidural or spinal anaesthesia: results from overview of randomised trials. BMJ (2000) 7.36

Effects of the angiotensin-receptor blocker telmisartan on cardiovascular events in high-risk patients intolerant to angiotensin-converting enzyme inhibitors: a randomised controlled trial. Lancet (2008) 7.05

Intensive glucose control and macrovascular outcomes in type 2 diabetes. Diabetologia (2009) 6.55

Effects of different regimens to lower blood pressure on major cardiovascular events in older and younger adults: meta-analysis of randomised trials. BMJ (2008) 6.13

Type-II diabetes and pancreatic cancer: a meta-analysis of 36 studies. Br J Cancer (2005) 6.06

Atherosclerotic disease of the aortic arch and the risk of ischemic stroke. N Engl J Med (1994) 6.05

Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis. JAMA (2005) 5.60

Serum cholesterol concentration and coronary heart disease in population with low cholesterol concentrations. BMJ (1991) 5.45

Use of proportional reporting ratios (PRRs) for signal generation from spontaneous adverse drug reaction reports. Pharmacoepidemiol Drug Saf (2002) 5.20

Mediating variable framework in physical activity interventions. How are we doing? How might we do better? Am J Prev Med (1998) 4.82

Structure and sequence of the rfb (O antigen) gene cluster of Salmonella serovar typhimurium (strain LT2). Mol Microbiol (1991) 4.76

Body mass index and cardiovascular disease in the Asia-Pacific Region: an overview of 33 cohorts involving 310 000 participants. Int J Epidemiol (2004) 4.67

Geographical variations in senile osteoporosis. The association with physical activity. J Bone Joint Surg Br (1970) 4.56

Mandated lowering of toxicants in cigarette smoke: a description of the World Health Organization TobReg proposal. Tob Control (2008) 4.37

Eph receptors and ligands comprise two major specificity subclasses and are reciprocally compartmentalized during embryogenesis. Neuron (1996) 4.12

Association and activation of Jak-Tyk kinases by CNTF-LIF-OSM-IL-6 beta receptor components. Science (1994) 4.07

Management of raised blood pressure in New Zealand: a discussion document. BMJ (1993) 3.96

The Emerging Risk Factors Collaboration: analysis of individual data on lipid, inflammatory and other markers in over 1.1 million participants in 104 prospective studies of cardiovascular diseases. Eur J Epidemiol (2007) 3.81

Measuring what works in health care. Science (1994) 3.77

Effect of socioeconomic group on incidence of, management of, and survival after myocardial infarction and coronary death: analysis of community coronary event register. BMJ (1997) 3.69

Blood pressure and cardiovascular disease in the Asia Pacific region. J Hypertens (2003) 3.67

Structure of the O antigen of Escherichia coli K-12 and the sequence of its rfb gene cluster. J Bacteriol (1994) 3.61

A requirement for the immediate early gene Zif268 in the expression of late LTP and long-term memories. Nat Neurosci (2001) 3.56

Neurological manifestations of enterovirus 71 infection in children during an outbreak of hand, foot, and mouth disease in Western Australia. Clin Infect Dis (2000) 3.41

Comparison of the prediction by 27 different factors of coronary heart disease and death in men and women of the Scottish Heart Health Study: cohort study. BMJ (1997) 3.40

Reliable assessment of the effects of treatment on mortality and major morbidity, I: clinical trials. Lancet (2001) 3.32

A three-item scale for the early prediction of stroke recovery. Lancet (2001) 3.15

Prevalence of parkinsonism and Parkinson's disease in Europe: the EUROPARKINSON Collaborative Study. European Community Concerted Action on the Epidemiology of Parkinson's disease. J Neurol Neurosurg Psychiatry (1997) 3.14

Envelope glycoprotein of HIV induces interference and cytolysis resistance in CD4+ cells: mechanism for persistence in AIDS. Cell (1988) 3.12

Blood pressure, antihypertensive drug treatment and the risks of stroke and of coronary heart disease. Br Med Bull (1994) 3.09

Sacral fractures: an important problem. Retrospective analysis of 236 cases. Clin Orthop Relat Res (1988) 3.04

Continuous intravenous heparin compared with intermittent subcutaneous heparin in the initial treatment of proximal-vein thrombosis. N Engl J Med (1986) 3.00

Comparative genome organization of vertebrates. The First International Workshop on Comparative Genome Organization. Mamm Genome (1996) 2.97

A full genome search in multiple sclerosis. Nat Genet (1996) 2.96

Thirsting and hypernatremic dehydration--a form of child abuse. Pediatrics (1970) 2.93

Obesity, alcohol, and tobacco as risk factors for cancers of the esophagus and gastric cardia: adenocarcinoma versus squamous cell carcinoma. Cancer Epidemiol Biomarkers Prev (1995) 2.92

Clinical effects of anticoagulant therapy in suspected acute myocardial infarction: systematic overview of randomised trials. BMJ (1996) 2.90

An orphan receptor tyrosine kinase family whose members serve as nonintegrin collagen receptors. Mol Cell (1997) 2.89

Genome shortcut leads to problems. Science (1993) 2.86

Effect of intravenous nitrates on mortality in acute myocardial infarction: an overview of the randomised trials. Lancet (1988) 2.84

CNTF and LIF act on neuronal cells via shared signaling pathways that involve the IL-6 signal transducing receptor component gp130. Cell (1992) 2.83

Blood glucose and risk of cardiovascular disease in the Asia Pacific region. Diabetes Care (2004) 2.77

Glucose levels predict hospitalization for congestive heart failure in patients at high cardiovascular risk. Circulation (2007) 2.76

Sex differences in myocardial infarction and coronary deaths in the Scottish MONICA population of Glasgow 1985 to 1991. Presentation, diagnosis, treatment, and 28-day case fatality of 3991 events in men and 1551 events in women. Circulation (1996) 2.76

National Institute of Mental Health Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE): Alzheimer disease trial methodology. Am J Geriatr Psychiatry (2001) 2.74

1999 World Health Organization-International Society of Hypertension Guidelines for the management of hypertension. Guidelines sub-committee of the World Health Organization. Clin Exp Hypertens (1999) 2.72

Evaluation of patient reporting of adverse drug reactions to the UK 'Yellow Card Scheme': literature review, descriptive and qualitative analyses, and questionnaire surveys. Health Technol Assess (2011) 2.71

Incidence of cancer in children in the United States. Sex-, race-, and 1-year age-specific rates by histologic type. Cancer (1995) 2.65

Seismicity remotely triggered by the magnitude 7.3 landers, california, earthquake. Science (1993) 2.61

Regional brain and ventricular volumes in Tourette syndrome. Arch Gen Psychiatry (2001) 2.59

Ambulatory blood pressure normality: results from the PAMELA study. J Hypertens (1995) 2.58

Why is mortality higher in Scotland than in England and Wales? Decreasing influence of socioeconomic deprivation between 1981 and 2001 supports the existence of a 'Scottish Effect'. J Public Health (Oxf) (2005) 2.58

Legalization of all drugs. CMAJ (1993) 2.58

Cholesterol, coronary heart disease, and stroke in the Asia Pacific region. Int J Epidemiol (2003) 2.57

Association of angiotensinogen gene T235 variant with increased risk of coronary heart disease. Lancet (1995) 2.52

Magnesium for acute stroke (Intravenous Magnesium Efficacy in Stroke trial): randomised controlled trial. Lancet (2004) 2.51

Accuracy of the estimated prevalence of obesity from self reported height and weight in an adult Scottish population. J Epidemiol Community Health (2000) 2.50

Pravastatin therapy and the risk of stroke. N Engl J Med (2000) 2.46

Refining the perfusion-diffusion mismatch hypothesis. Stroke (2005) 2.44

Do men and women respond differently to blood pressure-lowering treatment? Results of prospectively designed overviews of randomized trials. Eur Heart J (2008) 2.41

National study of microphthalmia, anophthalmia, and coloboma (MAC) in Scotland: investigation of genetic aetiology. J Med Genet (2002) 2.39

The effects of diabetes on the risks of major cardiovascular diseases and death in the Asia-Pacific region. Diabetes Care (2003) 2.36

Epidemiological characteristics of adenocarcinoma of the gastric cardia and distal stomach in the United States, 1973-1982. Int J Epidemiol (1988) 2.36

Ethnic comparisons of the cross-sectional relationships between measures of body size with diabetes and hypertension. Obes Rev (2008) 2.32

By neglecting deprivation, cardiovascular risk scoring will exacerbate social gradients in disease. Heart (2005) 2.32

trkB encodes a functional receptor for brain-derived neurotrophic factor and neurotrophin-3 but not nerve growth factor. Cell (1991) 2.31

Cyberspace offers chance to do 'virtually' real science. Science (1994) 2.29

Participants in prospective, randomized clinical trials for resected non-small cell lung cancer have improved survival compared with nonparticipants in such trials. Cancer (1985) 2.28

Association of HbA1c levels with vascular complications and death in patients with type 2 diabetes: evidence of glycaemic thresholds. Diabetologia (2011) 2.28

"I don't like Mondays"-day of the week of coronary heart disease deaths in Scotland: study of routinely collected data. BMJ (2000) 2.25

Cardiovascular risk prediction tools for populations in Asia. J Epidemiol Community Health (2007) 2.25

Osteomalacia--a common disease in elderly women. J Bone Joint Surg Br (1967) 2.24

First- v. second-generation antipsychotics and risk for diabetes in schizophrenia: systematic review and meta-analysis. Br J Psychiatry (2008) 2.24

Penile gangrene associated with chronic renal failure: report of 7 cases and review of the literature. J Urol (1994) 2.21

Effects of blood pressure lowering on cardiovascular risk according to baseline body-mass index: a meta-analysis of randomised trials. Lancet (2014) 2.18

Longitudinal study of blood pressure and white matter hyperintensities: the EVA MRI Cohort. Neurology (2001) 2.18

Mitochondrial and plasma membrane potentials cause unusual accumulation and retention of rhodamine 123 by human breast adenocarcinoma-derived MCF-7 cells. J Biol Chem (1985) 2.18